首页> 外文期刊>Histopathology: Official Journal of the British Division of the International Academy of Pathology >Reappraisal of Epstein-Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells
【24h】

Reappraisal of Epstein-Barr virus (EBV) in diffuse large B-cell lymphoma (DLBCL): comparative analysis between EBV-positive and EBV-negative DLBCL with EBV-positive bystander cells

机译:Epstein-Barr病毒(EBV)重新评估弥漫性大B细胞淋巴瘤(DLBCL):EBV阳性和EBV阴性DLBCL与EBV阳性旁观者细胞的比较分析

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) not otherwise specified is defined as monoclonal EBV+ B-cell proliferation affecting patients without any known immunosuppression. Non-neoplastic EBV+ cells proliferating in or adjacent to EBV- DLBCL were reported recently, but their clinical significance is unclear. Thus, the aim of this study was to investigate the prognostic impact of EBV+ cells in DLBCL.
机译:目的:Epstein-BARR病毒(EBV) - 阳性漫反射大B细胞淋巴瘤(DLBCL)未指定的定义为影响患者而没有任何已知免疫抑制的单克隆EBV + B细胞增殖。 最近报道了EBV-DLBCL中的非肿瘤eBV +细胞增殖或邻近EBV-DLBCL的细胞,但它们的临床意义尚不清楚。 因此,本研究的目的是探讨DLBCL中EBV +细胞的预后影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号